2026. IMMUNOTHERAPY COMBINATIONS IN STAGE IV CANCER: SYNERGISTIC EFFECTS AND CLINICAL OUTCOMES. Frontier in Medical and Health Research. 4, 1 (Jan. 2026), 94–107.